Cases & Deals

Global Blood Therapeutics develops patent portfolio of small molecule drug candidates for treatment of sickle cell disease

Clients Global Blood Therapeutics, Inc.

Jones Day represents Global Blood Therapeutics, Inc. in patent prosecution of small molecule drug candidates for treatment of sickle cell disease.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.